Suppr超能文献

[帕博利珠单抗给药后出现大疱性药物反应:两例病例报告]

[Bullous drug reaction after pembrolizumab administration: two case reports].

作者信息

Golle L, Michl C, Kreft B

机构信息

Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Deutschland.

出版信息

Dermatologie (Heidelb). 2022 Dec;73(12):959-964. doi: 10.1007/s00105-022-05018-0. Epub 2022 Jun 9.

Abstract

Severe, blistering, adverse drug reactions involving the skin include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Allopurinol, anticonvulsants, sulphonamide antibiotics and non-steroidal anti-inflammatory drugs in the oxicam class have been repeatedly described as triggers. Increasingly, immunotherapies are also coming into focus as triggers of severe skin reactions. Two patients with bullous skin symptoms after administration of the checkpoint inhibitor pembrolizumab are presented. As the clinical picture does not always allow an unequivocal classification, a histological assessment is often indispensable.

摘要

涉及皮肤的严重水疱性药物不良反应包括史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)。别嘌醇、抗惊厥药、磺胺类抗生素以及恶丙嗪类非甾体抗炎药一再被描述为引发因素。越来越多的免疫疗法也成为严重皮肤反应的引发因素。本文介绍了两名在使用检查点抑制剂派姆单抗后出现大疱性皮肤症状的患者。由于临床表现并不总是能明确分类,组织学评估往往必不可少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e6ed/9700574/dacd2b5bee8a/105_2022_5018_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验